Skip to content
Home/Companies/MedTech/Brosmed

Brosmed

MedTech·China·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Brosmed?

Brosmed is a Chinese MedTech company, currently owned by Cathay Capital since 2020.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap III · 2016 · Growth

Key facts

HQChina
SectorMedTech

More from Cathay Capital Small Cap III

Other portfolio companies in the same fund.

Aukey
Aukey
Active
ConsumerChina· 2020
Biose Industrie
Biose Industrie
Exited 2024
PharmaFrance· 2020
to L-GAM / BPI France (French Tech Souveraineté)
Deerma
Deerma
Active
ConsumerChina· 2020
EasyVista
EasyVista
Active
SaaSFrance· 2020
Fapon
Active
HealthcareChina· 2020
FuturMaster
FuturMaster
Active
SoftwareFrance· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Brosmed?

Brosmed is currently owned by Cathay Capital, through Cathay Capital Small Cap III, since 2020.

When did Cathay Capital acquire Brosmed?

Cathay Capital acquired Brosmed in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue